Cabaletta Bio to Participate in Upcoming Investor Conferences in September
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company, announced that the Company will participate in two upcoming investor conferences in September:
Cabaletta Bio to Participate in Upcoming Investor Conferences in September Read More